Cart
sales@molnova.com
(D-Phe12,Nle21·38,α-Me-Leu37)-CRF (12-41) (human, rat)
CAS No. ———
(D-Phe12,Nle21·38,α-Me-Leu37)-CRF (12-41) (human, rat)( ——— )
Catalog No. M40116 CAS No. ———
(D-Phe12,Nle21·38,α-Me-Leu37)-CRF (12-41) (human, rat)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(D-Phe12,Nle21·38,α-Me-Leu37)-CRF (12-41) (human, rat)
-
NoteResearch use only, not for human use.
-
Brief Description(D-Phe12,Nle21·38,α-Me-Leu37)-CRF (12-41) (human, rat)
-
Description(D-Phe12,Nle21·38,α-Me-Leu37)-CRF (12-41) (human, rat)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PAC1R antagonist 1
PAC1R antagonist 1 is an orally active PAC1 receptor antagonist that inhibits abnormal pain induced by pituitary adenylate cyclase-activating polypeptide (PACAP) and nerve damage, and may be used in the study of neoplasms and immune-related disorders.
-
α-Glucosidase-IN-23
α-Glucosidase-IN-23 is an orally active inhibitor of α-glucosidase that can decrease blood glucose levels by inhibiting α-glucosidase (IC50 = 4.48 μM).
-
Tricaine methanesulf...
Tricaine methanesulfonate (TMS) is an anesthetic.
